SEC Insider Transactions from Reents Scott T.

Last updated: 2026-03-14 11:55 UTC | Total transactions: 30

Scott T. Reents, EVP and Chief Financial Officer of AbbVie Inc. ($ABBV), sold shares on the open market once in the last year, totaling $3.75 million. His most recent sale occurred on March 14, 2025. This places his sales volume in 2,340th position among 11,678 insiders, below the average of $8.6 million per seller and 6.4 transactions. Reents made no open market purchases during this period.

Set Up your own filters →
Transaction Date Company Ticker Insider Name Title Transaction Type Security Shares Price Shares Owned Following Total Shares Outstanding % of Owned % of Outstanding
Feb. 27, 2026 AbbVie Inc. $ABBV Reents Scott T EVP, CHIEF FINANCIAL OFFICER F Common Stock, $0.01 par value 21638 $232.08 38,777.0000 1,773,000,000 35.82% 0.00%
Feb. 18, 2026 AbbVie Inc. $ABBV Reents Scott T EVP, CHIEF FINANCIAL OFFICER A Common Stock, $0.01 par value 25062 $0.00 36,639.0000 1,773,000,000 216.48% 0.00%
Feb. 18, 2026 AbbVie Inc. $ABBV Reents Scott T EVP, CHIEF FINANCIAL OFFICER A Option (Right to buy) 21937 $0.00 21,937.0000 1,773,000,000 9999.99% 0.00%
Feb. 18, 2026 AbbVie Inc. $ABBV Reents Scott T EVP, CHIEF FINANCIAL OFFICER A Common Stock, $0.01 par value 7260 $0.00 60,415.0000 1,773,000,000 13.66% 0.00%
Feb. 18, 2026 AbbVie Inc. $ABBV Reents Scott T EVP, CHIEF FINANCIAL OFFICER A Common Stock, $0.01 par value 7606 $0.00 53,155.0000 1,773,000,000 16.70% 0.00%
Feb. 18, 2026 AbbVie Inc. $ABBV Reents Scott T EVP, CHIEF FINANCIAL OFFICER A Common Stock, $0.01 par value 8910 $0.00 45,549.0000 1,773,000,000 24.32% 0.00%
March 14, 2025 AbbVie Inc. $ABBV Reents Scott T EVP, CHIEF FINANCIAL OFFICER S Common Stock, $0.01 par value 17644 $212.34 11,577.0000 1,773,000,000 60.38% 0.00%
Feb. 28, 2025 AbbVie Inc. $ABBV Reents Scott T EVP, CHIEF FINANCIAL OFFICER F Common Stock, $0.01 par value 10973 $205.02 29,221.0000 1,773,000,000 27.30% 0.00%
Feb. 13, 2025 AbbVie Inc. $ABBV Reents Scott T EVP, CHIEF FINANCIAL OFFICER A Common Stock, $0.01 par value 2398 $0.00 23,674.0000 1,773,000,000 11.27% 0.00%
Feb. 13, 2025 AbbVie Inc. $ABBV Reents Scott T EVP, CHIEF FINANCIAL OFFICER A Common Stock, $0.01 par value 8912 $0.00 32,586.0000 1,773,000,000 37.64% 0.00%
Feb. 13, 2025 AbbVie Inc. $ABBV Reents Scott T EVP, CHIEF FINANCIAL OFFICER A Common Stock, $0.01 par value 7608 $0.00 40,194.0000 1,773,000,000 23.35% 0.00%
Feb. 13, 2025 AbbVie Inc. $ABBV Reents Scott T EVP, CHIEF FINANCIAL OFFICER A Option (Right to buy) 27343 $0.00 27,343.0000 1,773,000,000 9999.99% 0.00%
Feb. 13, 2025 AbbVie Inc. $ABBV Reents Scott T EVP, CHIEF FINANCIAL OFFICER A Common Stock, $0.01 par value 5845 $0.00 21,276.0000 1,773,000,000 37.88% 0.00%
Feb. 23, 2024 AbbVie Inc. $ABBV Reents Scott T EVP, CHIEF FINANCIAL OFFICER M Common Stock, $0.01 par value 14140 $61.36 41,205.0000 1,773,000,000 52.24% 0.00%
Feb. 23, 2024 AbbVie Inc. $ABBV Reents Scott T EVP, CHIEF FINANCIAL OFFICER S Common Stock, $0.01 par value 14140 $177.44 27,065.0000 1,773,000,000 34.32% 0.00%
Feb. 28, 2024 AbbVie Inc. $ABBV Reents Scott T EVP, CHIEF FINANCIAL OFFICER F Common Stock, $0.01 par value 11634 $178.99 15,431.0000 1,773,000,000 42.99% 0.00%
Feb. 23, 2024 AbbVie Inc. $ABBV Reents Scott T EVP, CHIEF FINANCIAL OFFICER M Option (Right to buy) 14140 $61.36 17,380.0000 1,773,000,000 44.86% 0.00%
Feb. 15, 2024 AbbVie Inc. $ABBV Reents Scott T EVP, CHIEF FINANCIAL OFFICER A Common Stock, $0.01 par value 8912 $0.00 27,065.0000 1,773,000,000 49.09% 0.00%
Feb. 15, 2024 AbbVie Inc. $ABBV Reents Scott T EVP, CHIEF FINANCIAL OFFICER A Option (Right to buy) 31520 $0.00 31,520.0000 1,773,000,000 9999.99% 0.00%
Feb. 15, 2024 AbbVie Inc. $ABBV Reents Scott T EVP, CHIEF FINANCIAL OFFICER A Common Stock, $0.01 par value 11800 $0.00 12,609.0000 1,773,000,000 1458.59% 0.00%
Feb. 15, 2024 AbbVie Inc. $ABBV Reents Scott T EVP, CHIEF FINANCIAL OFFICER A Common Stock, $0.01 par value 3146 $0.00 15,755.0000 1,773,000,000 24.95% 0.00%
Feb. 15, 2024 AbbVie Inc. $ABBV Reents Scott T EVP, CHIEF FINANCIAL OFFICER A Common Stock, $0.01 par value 2398 $0.00 18,153.0000 1,773,000,000 15.22% 0.00%
March 1, 2023 AbbVie Inc. $ABBV Reents Scott T EVP, CHIEF FINANCIAL OFFICER S Common Stock, $0.01 par value 15092 $153.06 1,659.0000 1,778,000,000 90.10% 0.00%
March 1, 2023 AbbVie Inc. $ABBV Reents Scott T EVP, CHIEF FINANCIAL OFFICER S Common Stock, $0.01 par value 850 $153.38 809.0000 1,778,000,000 51.24% 0.00%
Feb. 28, 2023 AbbVie Inc. $ABBV Reents Scott T EVP, CHIEF FINANCIAL OFFICER F Common Stock, $0.01 par value 12683 $154.28 16,751.0000 1,778,000,000 43.09% 0.00%
Feb. 16, 2023 AbbVie Inc. $ABBV Reents Scott T EVP, CHIEF FINANCIAL OFFICER A Option (Right to buy) 33760 $0.00 33,760.0000 1,778,000,000 9999.99% 0.00%
Feb. 16, 2023 AbbVie Inc. $ABBV Reents Scott T EVP, CHIEF FINANCIAL OFFICER A Common Stock, $0.01 par value 2398 $0.00 29,434.0000 1,778,000,000 8.87% 0.00%
Feb. 16, 2023 AbbVie Inc. $ABBV Reents Scott T EVP, CHIEF FINANCIAL OFFICER A Common Stock, $0.01 par value 3146 $0.00 27,036.0000 1,778,000,000 13.17% 0.00%
Feb. 16, 2023 AbbVie Inc. $ABBV Reents Scott T EVP, CHIEF FINANCIAL OFFICER A Common Stock, $0.01 par value 4366 $0.00 23,890.0000 1,778,000,000 22.36% 0.00%
Feb. 16, 2023 AbbVie Inc. $ABBV Reents Scott T EVP, CHIEF FINANCIAL OFFICER A Common Stock, $0.01 par value 18715 $0.00 19,524.0000 1,778,000,000 2313.35% 0.00%